Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of lebrikizumab in adults with mild to moderate asthma
2013-004625-81Phase 3Completed
- Sponsor
- Roche
- Start
- Jun 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asthma comparing Lebrikizumab with Placebo (2 arms). Primary endpoint: Absolute change in pre-bronchodilator FEV1. Started Jun 2014; status: completed.
02
Drugs
lebrikizumab
03
Conditions
asthma
Beyond the preview
Go deeper on 2013-004625-81.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004625-81.